Overview
This phase IV trial examines the impact of an education program on the human papilloma virus (HPV) and its effects on the acceptance and completion rates of a free HPV vaccination program in underserved adult patients. Participating in the HPV educational program may increase the HPV vaccination rates among low income uninsured adult patients and ultimately prevent HPV related cancers.
Description
PRIMARY OBJECTIVES:
I. Determine the acceptability and completion rates of free HPV vaccination among the underserved adult patients at the Volunteer in Medicine Clinic (VIM) in Jacksonville, Florida.
II. Determine if an education program on HPV vaccination increases the acceptability of free HPV vaccination among the underserved adult patients at the Volunteer in Medicine Clinic (VIM) in Jacksonville, Florida.
III. Determine the baseline prevalence of HPV vaccination completion rates among VIM patients age 18-45.
IV. Determine if there are differences in acceptance and completion rates of HPV vaccination, among VIM patients of different sex, age (18-26 versus [vs] 27-45), ethnicity or race, following an education program on HPV as part of this protocol participation.
- OUTLINE
Patients receive educational materials on HPV and are asked of their willingness to proceed with the first HPV vaccination. Patients who express interest in receiving the HPV vaccination, then receive the first dose of the HPV vaccine and the next 2 doses approximately 2 months and 6 months following the initial vaccine.
Eligibility
Inclusion Criteria:
- Patient of VIM clinic
- No history of HPV vaccination
- No history of allergy to HPV vaccination contents
- Willingness to participate in clinical trial
- For female patients, no history of positive HPV testing or abnormal Papanicolaou (Pap) smears
- Patients who read and understand English
Exclusion Criteria:
- Individuals who had previously received the HPV vaccine